Breaking News

Tweet TWEET

Regeneron to Report Fourth Quarter and Full Year 2012 Financial and Operating Results and Host Conference Call and Webcast on

Regeneron to Report Fourth Quarter and Full Year 2012 Financial and Operating
      Results and Host Conference Call and Webcast on February 14, 2013

PR Newswire

TARRYTOWN, N.Y., Jan. 28, 2013

TARRYTOWN, N.Y., Jan. 28, 2013 /PRNewswire/ --Regeneron Pharmaceuticals, Inc.
(NASDAQ:REGN)  today announced that it will report its fourth quarter and full
year 2012 financial and operating results on Thursday, February 14, 2013,
before the U.S. financial markets open. The Company will host a conference
call and simultaneous webcast at 8:30 AM EST that day.

Conference Call Information

To access this call, dial (888) 660-6127 (U.S.) or (973) 890-8355
(International). A link to the webcast may be accessed from the 'Events and
Presentations' page of Regeneron's website at www.regeneron.com. A replay of
the conference call and webcast will be archived on the Company's website and
will be available for 30 days.

About Regeneron Pharmaceuticals, Inc.

Regeneron is a leading science-based biopharmaceutical company based in
Tarrytown, New York that discovers, invents, develops, manufactures, and
commercializes medicines for the treatment of serious medical conditions.
Regeneron markets medicines for eye diseases, colorectal cancer, and a rare
inflammatory condition and has product candidates in development in other
areas of high unmet medical need, including hypercholesterolemia, rheumatoid
arthritis, and asthma. For additional information about the company, please
visit www.regeneron.com.

Contact Information:
Michael Aberman, M.D.         Peter Dworkin
Investor Relations            Corporate
                              Communications
914-847-7799                  914.847.7640 
michael.aberman@regeneron.com peter.dworkin@regeneron.com



SOURCE Regeneron Pharmaceuticals, Inc.

Website: http://www.regeneron.com
 
Press spacebar to pause and continue. Press esc to stop.